For patients diagnosed with IDH mutated anaplastic glioma the potential for survival extending beyond 10–15 years is high based on the long term outcome of the RTOG9402 and EORTC26951trials published in 2013 [1, 2]. The gene discussed is IDH1; the disease is grade III glioma.